$SEM Stock Notification: Current Shareholder of Select Medical? Contact BFA Law about its Ongoing Investigation into the Board Over $16.50 per share Acquisition

▤ Summary

Select Medical announced a pending sale at $16.50 per share to a buyer consortium led by company insiders and Welsh, Carson, Anderson & Stowe. A law firm is now investigating whether the board and senior management breached fiduciary duties in connection with that deal. The shareholder vote is set for June 26, 2026, and the merger could close soon after. Public shareholders do not get the same rollover opportunity offered to certain insiders, which is driving the scrutiny. This event is relevant to healthcare software watchers because it signals a major ownership change at a healthcare services company that may affect technology buying priorities.

▦ Linked Companies